A solid combo.
In murine models, oxaliplatin with immune checkpoint inhibition activates tumor macrophages to induce CAR-T cell recruitment, cracking the door for CAR-T cell use in solid tumors. | Srivastava, Cancer Cell 2020
Search This Blog
With increasing information overload and packed work schedules, staying up-to-date on the newest oncologic advances is harder than ever. But take heart! The QuadShot is freshly brewed in your inbox four mornings each week so you can quickly down and digest the day's most pertinent cancer news.
The method of execution is really impressive of writers of this blog. This team does really work hard and brings new information to its readers. I am connected with this blog very long and I am really thankful kubet lua dao
ReplyDelete